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Abstract 
Background: : Acid peptic disease is the condition in which there is either  excessive secretion of acid and 
pepsin or a weakened stomach mucosal defence, which is responsible for damage to the delicate mucosa and the 
lining of the stomach, oesophagus and duodenum resulting in ulceration.Parinama shoola in Ayurveda is 
comparable with Acid peptic disease. 
Aim of study: The Aim of the study is to evaluate and compare the effect of indigenous compound drugs 
(Shatavari mandoor and Pippali ghrita) in uncomplicated cases of Parinam shoola. 
Methods:  This is a prospective, open labelled, randomised clinical tr ial. A total of 31 patients suggestive of 
features of Parinama Shoola (acid peptic disorder) were enrolled and were randomly divided in two groups- 12 
patients were enrolled in group A and were given trial drug Shatavari mandoor,19 patients were enrolled in group 
B and were given trial drug Pippali ghrita. Duration of study was 3 months. 
Results: Individually both groups showed statistically significant improvement in clinical symptoms i.e. pain 
in abdomen, epigastric burning, nausea, flatulence, loss of appetite and constipation (p<0.01), but the mean 
reduction in the symptoms of group A (Shatavari mandoor group) is more than group B (Pippali ghrita group). 
Conclusion: Both tr ial drugs are effective in the treatment of Parinama shoola. Shatavari mandoor is more 
effective in the treatment of Parinam shoola in comparison to Pippali ghrita. 
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Introduction: 
An ulcer is defined as disruption of mucosal 
integrity of stomach and or duodenum leading to local 
defect or excavation due to active inflammation.  
Peptic ulcers are estimated to occur in 6-15% of 
general population. The incidence of peptic ulcer 
declined steadily from 1960-1980 and then remained 
stable since then. (1) 
The cardinal feature of peptic ulcer disease is 
epigastric pain which is characterised by gnawing or 
burning, may be ill defined, may be aggravated by meals 
or relieved few minutes after meals. Other associated 
symptoms include nausea, vomiting flatulence, 
abdominal distension, water brash etc. 
In Ayurveda, Parinama shoola is a disease in 
which abdominal pain during digestion is observed. The 
aetiology, pathogenesis and clinical manifestation of 
Parinama shoola have got a striking similarity with acid 
peptic disorders in modern medicine.  
The disease Parinama shoola was first mentioned 
by Madhavakara. In the aetio pathogenesis of Parinama 
shoola Madhavakar has given much importance to vata 
(2) in causing the disease, whereas Vijay rakshita in 
explaning the disease gave a specific and scientific 
pathogenesis of Parinama shoola. According to Vijay 
rakshita, Parinama shoola is a disease of tridosha, pitta 
predominance is present as the pain occurs during the 
period of digestion. (2) 
In Parinama shoola abdominal pain occurs at the 
phase of digestion. ‘Bhukte Jeeryati yata Shoolam 
Tadeva Parinamajam’ (3) 
Three dosas i.e. vata, pitta and kapha are 
involved in the pathogenesis of Parinama shoola. In all 
types of shoola (pain), vayu is the predominant 
causative dosha which is correlated with sympathetic 
nervous mechanism of sensation of pain in the 
abdominal visceral organ. Kapha refers to the kledaka 
kapha which has parlance with mucus gel layer and 
mucin of modern medicine. So kapha is for defensive 
mechanism in the pathogenesis of Parinama shoola.Pitta 
is related with HCL and pepsin and it is for aggressive 
mechanism causative for Parinama shoola. 
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Two trial drugs, Shatavari mandoor and Pippali 
ghrita were selected for the present study. 
Many previous studies (clinical and experimental) 
regarding the antiulcer effect of Shatavari mandoor were 
done, which showed promising results in cases of acid 
peptic disorders. (4,5) 
Pippali ghrita  has been described in Chakra 
dutta in the context of Parinama shoola. According to 
Chakra dutta, Pippali ghrita has been able to treat 
complicated cases of Parinama shoola. (6) and thus it 
was assumed that Pippali Ghrita would be beneficial in 
patients of Parinaana Shoola. 
This study revealed the effect of herbomineral 
drugs (Shatavari mandoor & Pippali ghrita ) in the 
treatment of Parinama shoola. 
 
Material & Methods 
Study design: It is a prospective, randomised, open 
labelled, parallel designed, clinical study. 
 
Inclusion criteria 
 Patients showing clinical signs and symptoms 
suggestive of Parinama shoola like pain in epigastric 
pain, heartburn, acid eructation, water brash etc.  
Subjects above 20 years and below 60 years  
 
Exclusion criteria 
 Pregnant and lactating mothers  
 Patients having gall bladder disease, worm infestation, 
cardiovascular and liver disorders. 
 Malignant and complicated ulcers  
 
Grouping of patients 
Patients were randomly divided into two groups 
Group A: 12 Patients were included in group A and 
were administered with trial drug Shatavari mandoor. 
Group B: 19 Patients were included in group B and 
were administered with trial drug Pippali ghrita. 
 
Criteria of assessment 
Clinical signs and symptoms: Udarasula (pain in 
abdomen), utklesa (feeling of nausea and vomiting), 
aruci (loss of appetite), hritkaṇṭhadaha (heart burn) etc. 
were assessed before and after the treatment. Clinical 
assessment was made by grading as 0,1,2,3 on the basis 
of severity. 
 
Grading pattern for signs and symptoms 
Udar shoola (epigastric pain)  
Grade-0: No Pain 
Grade-1: Mild pain 
Grade-2: Moderate pain 
Grade-3: Severe pain 
 
Hrikantha daha (burning in epigastric region) 
Grade-0: No Heart burn 
Grade-1: Occasional retrosternal burning 
Grade-2: Retrosternal burning 1-2 times; relieved by 
food or antacids 
Grade-3: Frequent retrosternal burning 
 
Utklesh (nausea) 
Grade-0: Absent nausea 
Grade-1: Occasional desire to vomit 
Grade-2: Frequent desire to vomit 
Grade-3: Regular desire to vomit 
 
Adhmaan (flatulence)   
Grade-0: Absent feeling of gaseous distension 
Grade-1: Occasional feeling of gaseous distension 
Grade-2: Frequent feeling of gaseous Distension 
 
Aruchi (loss of appetite)   
Grade-0: Normal appetite 
Grade-1: Mild loss of appetite 
Grade-2: Moderate loss of appetite 
Grade-3 Severe loss of appetite 
 
Praseka (water brash)  
Grade-0: No complaint of water brash 
Grade-1: Occasional feeling of water 
Grade-2: Frequent complaint of watery mouth 
Grade-3: Regular complaint of watery mouth 
 
Treatment Protocol 
Trial Drugs  
Table 1: Ingredients of trial drugs (all the par ts of 
ingredients were taken by weight) 
 
 
Method of preparation of trial drugs 
Method of preparation of Shatavari mandoor 
 Two parts of Mandoor bhasma, two parts of fresh 
juice of Shatavari swaras, two parts of cow’s curd and 
milk and one part of cow’s ghee were mixed and heated 
at low temp till the water content is evaporated and 
whole material becomes dry. 
Dose: 1.5 gm. Bid 
Mode of administration: Patients were advised to take 
the drug twice daily along with the meal. Drug is divided 
approximately into three parts, which should be taken in 
Shatavari Mandoor (7) 
Shatavari swarasa 2 parts 
Mandur churna 2 parts 
Godugdha 2 parts 
Godadhi 1 parts 
Go Ghrita 1 parts 
 
Pippali Ghrita (6) 
 
Pippali Kawatha 4 parts 
Pippali Kalka 1 part 
Go Ghrita 1 part 
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the first, middle and last bolus of the food. 
 
Method of preparation of  Pippali ghrita 
 Four parts of Pippali kawatha, one part of Pippali 
kalka and one part of Go ghrita are mixed together and 
heated till ghrita is prepared 
Dose: 5 gm. Bid 
Anupana : Sukoshana dugdha (Luke warm milk) 
 
Follow up: 
 Total duration of treatment was 3 months. The 
symptoms and signs of patients were recorded in detail 
once in a month before and during the treatment.  
 
Statistical analysis 
 The data obtained in clinical studies before and 
after treatment was expressed in terms of mean, 
standard deviation. Appropriate t’ test was applied to 
test the significance of comparative mean values of 
before and after treatment. 
 
Observation and results 
The study of demographic profile displayed that 
Parinama shoola was more prevalent among males 
(60%), between the age group of 20-50 years, most of 
the patients belong to rural areas (63.3%), having spicy 
dietary habit (37%) and vata-pitta deha prakriti 
(43.6%), the sharad ritu (33.3%) and rajasika manas 
prakriti (66.6%), 20% of the patients were having 
anxiety and 13% of patients were having depression in 
the study. Regarding addiction (6.67%) were addicted to 
smoking (23.3%) to tobacco chewing and (3.33%) to 
consumption to alcohol. [Table 2] 
Most common symptoms observed were udar 
shoola (epigastric pain), hrikantha daha (burning in 
epigastric region), utklesh (nausea), adhmaan 
(flatulence)  along with these, aruchi (loss of appetite), 
vibandha (constipation) and praseka (water brash) were 
also present in the patients of Parinama shoola. 
In Group A significant improvement was 
observed in epigastric pain (p<0.001), heart burn 
(p<0.01), loss of appetite (p<0.01), water brash 
(p<0.02), flatulence (p<0.02), constipation, (p<0.02), 
nausea (p<0.01). [Table-3]. 
In Group B significant improvement was 
observed in epigastric pain (p<0.001), heart burn 
(p<0.001), loss of appetite (p<0.01), water brash 
(p<0.05), flatulence (p<0.01), constipation, (p<0.001), 
nausea (p<0.01). [Table-3] 
 
Table 2: Demographic profile 
 
 
Table 3: Effect of treatment on clinical sign and 
symptoms 
Observations Percentage 
Habitat 
Rural 
Urban 
  
63.33 
36.66 
Addiction 
Tobacco 
Smoking 
Alcohol 
  
23.33 
6.67 
3.33 
Deha prakruti 
Vataja 
Pittaja 
Vāta-paittika 
  
18.33 
21.66 
43.66 
Manasa Prikriti 
Rajas 
Tamas 
  
66.6 
33.3 
Psyche phenomenon 
Anxiety 
Depression 
  
20 
13.33  
Dietary habits 
Spicy food 
  
37 
 Kala 
Sarad ritu 
Hemanta ritu 
Vasanta ritu 
  
33.3 
23.3 
16.6 
Clinical 
signs & 
symptoms 
Gro
up 
BT 
Mean 
± SD 
AT 
Mean 
± SD 
T P 
A 2.58 
±0.51 
0.75 
±0.45 
11.0 P<0.001 Udarasu-
la   
B 2.58 
±0.51 
1.74 
±0.45 
9.8 p<0.001 
Aruchi   A 1.33 
±0.98 
0.42 
±0.51 
4.0 p<0.01 
B 1.05 
±1.18 
0.58 
±0.69 
3.37 p<0.01 
Utklesa   A 1.08 
±1.00 
0.42 
±0.67 
4.69 p<0.01 
B 1.37 
±0.90 
0.95 
±0.71 
3.62 p<0.01 
Hritkan-
thadaha   
A 1.83 
±0.94 
0.92 
±0.67 
4.75 p<0.001 
B 1.89 
±0.81 
1.26 
±0.69 
5.53 p<0.001 
Adhmana   A 0.75 
±0.62 
0.33 
±0.49 
2.80 p<0.02 
B 1.21 
±0.79 
0.74 
±0.56 
2.96 p<0.001 
Praseka   A 0.83 
±0.83 
0.42 
±0.51 
2.80 P<0.02 
B 0.42 
±0.77 
0.21 
±0.45 
2.14 p<0.05 
Vibandha   A 1.17 
±1.03 
0.58 
±0.67 
3.02 p<0.02 
B 1.21 
±0.71 
0.58 
±0.51 
5.55 p<0.001 
Observations Percentage 
Age 
20 years-50 years 
  
86.6 
Sex 
Male 
Female 
  
60 
40 
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Discussion:  
Acid peptic disorder becomes a significant 
problem in the medical world because of its higher 
incidence, incomplete aetio-pathogenesis, relapse and 
severe consequences. In spite of phenomenal process in 
H. pylori researches a great relapses in APD are found. 
A relative failure of modern medicine has made the 
majority of population to turn towards alternative 
system of medicine. 
In the present study regarding age, high incidence 
was observed in between 2nd, 3rd and 4th decade of age 
group which may be due to pitta predominance in this 
age. In this study males were 60% and 40% were 
females. Thus it appears the disease of male 
predominance. 
Vata-pitta trait of deha prakriti (43.33%) and 
rajasika type of manasa prikriti (63.33%) persons are 
more prone to acid-peptic –diseases. Thus suggesting 
that Parinama shoola is a vata-pitta predominant 
disease. 
Certainly, the influence of kala (season) is present 
in Parinamashoola.It has been indicated in this study in 
the form of high incidence (33.33%) of the disease in 
patients during Sharad ritu (autumn season). Sharad ritu 
has been considered as the pitta prakopaka kala, thus the 
incidence of the disease in this kala suggests the 
prominence of pitta in Parinama shool. 
Observations regarding dietary habits showed that 
people who used to take spicy diet were more prone to 
develop this disease than those patients who were taking 
ordinary diet, thus suggesting that pitta prakopaka ahara 
(aggravating diet) aggravates the disease, indicating that 
Parinama shoola is a pitta predominant disease.  
Statistical data revealed that the trial drugs 
showed statistically significant improvement in udar 
sholoa, aruchi, utklesha, hritkantha daha, adhmana, 
vibandha, and praseka (p<0.01) 
In udarshoola (epigastric pain), both the trial 
drugs showed statistically highly significant 
improvement(p<0.001), but the mean decrease in the 
intensity of epigastric pain of group B was found lesser 
as compared to group A, which suggested that trial drug 
Shatavari mandoor is more effective in improving 
epigastric pain in comparison to Pippali ghrita in 
patients of Parinama shoola. 
Similarly, both the trial drugs also showed 
statistically significant improvement (p<0.001) in hrit 
kantha daha (epigastric burning), but the mean 
decrease in this symptom in group A was more in 
comparison to group B, thus indicating that Shatavari 
mandoor is having more pitta shamak action in 
comparison to Pippali ghrita.  
Statistical data revealed that, constipation is 
significantly reduced in both groups at the end of the 
treatment but highly significant improvement was 
observed in group B (p<0.001). Also, group B showed 
highly significant improvement in flatulence (p<0.001) 
in comparison to group A (p<0.01), thus indicating the 
vata shamak action of Pippali ghrita. 
 
Mode of action of trial drugs: 
Trial drug Shatavari mandoor is a herbomineral 
compound which consists of Mandoor bhasma, 
Shatavari swaras, Goghrit, Godugha, and Gavya dahi. 
(7) 
Pharmacological properties of Shatavari 
(Asparagus racemosus) are madhur tikta rasa, pichala- 
snigdha guna, sheeta veerya and madhur vipaka (8).  
Several clinical studies showed the antiulcer 
effect of Shatavari. (9,10) 
Mandoor is kashaya in rasa, sheeta, guru, pitta 
shamak in guna (property). Go dudha and Go ghrita 
are sheeta, madhur and vata-pitta nashaka. 
These properties of Shatavari Mandoor helps in 
pacification of pitta and vata, (7) which are the main 
aggravating factors in the pathogenesis of Parinama 
shoola.  
Also several clinical studies regarding the 
antiulcer properties of Shatavari mandoor have been 
conducted and revealed its antiulcer effect owing to 
strengthen mucosal defence mechanism in acid peptic 
disorders. (4,5) 
Second trial drug is Pippali ghrita which consists 
of Pippali kawatha, Pippali kalka, Go ghrita.(6) 
Pippai (Piper longum) is katu rasa pradhan, 
snigdha and ushna in guna (property) and vatanulomak 
in action. (11) 
Pippali can act as vatanulomak (pacifies 
abdominal gases) and shoola prashmak due to its 
snigdha –ushna guna, agni deepan (improving digestive 
fire) due to katu rasa. Ghrita is having the property of 
vata- pittahara, shoola-prasamana (pain relieving), 
snehana, agnideepan (improving digestive fire). Ghrita 
has also been claimed a good vranaropak.(ulcer 
protective property). Thus drug may act as cyto-
protective (barrier of acid-pepsin in the epithelial lining 
of stomach, duodenum) in the patients of Parinama 
shoola.  
An experimental study, has also showed antiulcer 
effect of Piper longum in rats. (12) 
Thus, the antiulcer property of the trial drugs 
Shatavari Mandoor and Pippali ghrita, is probably 
owing to their cytoprotective, shoola prashmak and 
vatanulomaka action. 
 
Conclusion:  
This is evident from both clinical and statistical 
improvement that the drugs Shatavari mandoor and 
Pippali ghrita are effective in the treatment of 
Parinama shoola and their ulcer protective effect may 
be through promotion of defensive mucosal mechanism 
rather than affecting the offensive acid-pepsin secretion. 
It was observed that, Shatavari mandoor is more 
effective in relieving symptoms like burning sensation 
whereas Pippali ghrita is more effective in relieving 
symptoms like flatulence and constipation in patients of 
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Parinaam shoola. 
Thus, it can be concluded from the present study 
that Pippali ghrita would be effective in vata 
predominant Parinaam shoola and Shatavari mandoor 
would be effective in pitta predominant Parinaam 
shoola. 
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